
1. Woynarowska B, Dimitroff, C.J, Skrincosky D, Sharma M, Matta K, Bernacki RJ. The effect of a 4-fluoro-glucosamine analog on the adhesion of human colon carcinoma HT-29 cells, Glycoconjugate J., 1996; 13(4):663-674.
2. Dimitroff CJ, Sharma A, Bernacki RJ. Cancer metastasis: a search for therapeutic inhibition (Review), Cancer Invest., 1998; 16(4):279-290, 1998.
3. Dimitroff, C.J., Pera, P., Dall’Olio, F., Matta, K.L., Chandrasekaran, E.V., Lau, J.T. and Bernacki, R.J. Cell surface N-acetylneuraminic acid 2,3-galactoside-dependent intercellular adhesion of human colon cancer cells, Biochem. Biophys. Res. Comm., 256:631-636, 1999.
4. Dimitroff CJ, Klohs W, Sharma A, Pera P, Driscoll D, Veith J, Steinkampf R, Schroeder M, Klutchko S, Sumlin A, Henderson B, Dougherty TJ, Bernacki RJ. Anti-angiogenic activity of selected receptor tyrosine kinase inhibitors, PD166285 and PD173074: implications for combination treatment with photodynamic therapy, Invest. New Drugs, 1999; 17(2):121-135.
5. Sackstein R, Dimitroff CJ. A hematopoietic cell L-selectin ligand that is distinct from PSGL-1 and displays N-glycan-dependent binding activity, Blood, 2000; 96: 2765-2774.
6. Dimitroff CJ, Lee J, Fuhlbrigge RC, Sackstein R. A distinct glycoform of CD44 is an L-selectin ligand on human hematopoietic progenitor cells. Proc. Natl. Acad. Sci., 2000; 97(25), 13841-13846.
7. Dimitroff CJ, Lee JY, Rafii S, Fuhlbrigge RC, Sackstein R. CD44 is a major E-selectin ligand on human hematopoietic progenitor cells. J. Cell Biology, 2001; 153:1277-1286.
8. Dimitroff CJ, Lee JY, Schor K, Sandmaier B, Sackstein R. Differential L-selectin binding activities of human hematopoietic cell L-selectin ligands, HCELL and PSGL-1. J. Biol. Chem., 2001; 276(50):47623-47631
9. Fuhlbrigge R.C, King S, Dimitroff CJ, Kupper TS, Sackstein R. Direct real-time observation of E-and P-selectin-mediated rolling on cutaneous lymphocyte-associated antigen immobilized on western blots. J. Immunology, 2002; 168:5645-51.
10. Dimitroff CJ, Bernacki RJ, Sackstein R. Glycosylation-dependent inhibition of cutaneous lymphocyte-associated antigen: Implications in modulating lymphocyte migration to skin. Blood, 2003; 101(2):602-610.
11. Dimitroff CJ, Kupper TS, Sackstein R. Prevention of leukocytic migration to inflamed skin with a novel fluorosugar modifier of cutaneous lymphocyte-associated antigen. J. Clin. Invest., 2003; 112, 1008-1018.
12. Dimitroff CJ, Lechpammer M, Long-Woodward, D, Kutok, JL. Rolling of Human Bone-Metastatic Prostate Tumor Cells on Human Bone Marrow Endothelial Cells under Shear Flow is Mediated by E-selectin. Cancer Research, 2004; 64 (15): 5261-5269.
13. Dimitroff CJ, Descheny L, Trujillo N, Kim R, Huang W, Nguyen V, Pienta K, Kutok JL, Rubin MA. Identification of Leukocyte E-selectin Ligands, P-selectin Glycoprotein Ligand-1 and E-selectin Ligand-1, on Human Metastatic Prostate Tumor Cells. Cancer Research, 2005; 65(13):5750-5760.
14. Dimitroff CJ. Sharing of the Same Vascular Addressins for Osteotropic Behavior of Hematopoietic Progenitor Cells and Cancer. BoneKEy-Osteovision., 2005; 2(10):16-19.
15. Descheny L, Gainers ME, Walcheck B, Dimitroff CJ. Ameliorating Skin-Homing Receptors on Malignant T cells with a Fluorosugar Analog of N-acetylglucosamine: P-selectin Ligand is a More Sensitive Target than E-selectin Ligand, J Invest Dermatol. 126(9):2065-73, 2006.
16. Alcaide P, King SL, Dimitroff CJ, Lim Y-C, Fuhlbrigge RC, Luscinskas FW. The 130-kDa glycoform of CD43 is an E-selectin ligand for activated Th1 cells in vitro and in delayed-type hypersensitivity reactions in vivo. J. Invest. Derm., 2007; 127(8):1964-72.
17. Barthel SB, Gavino J, Dimitroff CJ. Targeting selectin – selectin ligand interactions in inflammation and cancer. Expert Opin. Ther. Targets, 2007; 11(11):1473-1491.
18. Gainers ME, Descheny L, Barthel SB, ME, Liu L, Wurbel M, Dimitroff CJ. Skin-homing receptors on effector leukocytes are differentially sensitive to glyco-metabolic antagonism in allergic contact dermatitis. J. Immunology, 2007;179(12):8509-8518.
19. Yamanaka K, Dimitroff CJ, Fuhlbrigge RC, Kakeda M, Kurokawa I, Mizutani H, Kupper TS. Vitamins A and D are potent inhibitors of cutaneous lymphocyte-associated antigen expression. J. Allergy Clin. Immunol., In press.